Who has invested in HotSpot Therapeutics?

Atlas Venture are named among the investors backing HotSpot Therapeutics.

HotSpot Therapeutics Funding: $210M Raised, Series C (2021)

HotSpot Therapeutics funding overview

HotSpot Therapeutics is based in Boston. HotSpot Therapeutics has raised $210M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in November 2021. The round record for HotSpot Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Atlas Venture.

HotSpot Therapeutics at a glance

Total raised: $210M
Latest round: Series C
Latest round date: November 2021
Headquarters: Boston
Notable investors: Atlas Venture

Frequently asked about HotSpot Therapeutics funding

How much has HotSpot Therapeutics raised?: HotSpot Therapeutics has raised $210M in total disclosed funding across the rounds on record.
Who has invested in HotSpot Therapeutics?: Atlas Venture are named among the investors backing HotSpot Therapeutics.
What was the latest HotSpot Therapeutics funding round?: The most recent disclosed round is a Series C, announced in November 2021.
Where is HotSpot Therapeutics based?: HotSpot Therapeutics is based in Boston.
When did HotSpot Therapeutics last raise?: The last disclosed HotSpot Therapeutics round closed in November 2021 at Series C.

Totals shown for HotSpot Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.

HotSpot Therapeutics Funding: $210M Raised, Series C (2021)

HotSpot Therapeutics funding overview

HotSpot Therapeutics at a glance

Frequently asked about HotSpot Therapeutics funding

Companies related to HotSpot Therapeutics (34)

Browse related funding lists (6)